Stock listing

ELTX Stock Price, News, Filings & Events — Elicio Therapeutics, Inc.

Selected listing: ELTX · BOATS · USD · US

This page tracks Elicio Therapeutics, Inc.'s ELTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ELTX:BOATS. ELTX:BOATS is the stock-level entry point for investors researching Elicio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elicio Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker ELTX. The company focuses on developing innovative therapies for cancer treatment. With a market capitalization of approximately $70.4 million, Elicio Therapeutics is positioned within the growing biotech sector.

ELTX:BOATSUSDUSUpdated September 11, 2026
Elicio Therapeutics, Inc. logo
Ticker
ELTX:BOATS
Asset type
Stock
Market cap
$53.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
BOATS
Currency
USD

Elicio Therapeutics, Inc. ELTX:BOATS stock context

This page tracks Elicio Therapeutics, Inc.'s ELTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ELTX:BOATS. ELTX:BOATS is the stock-level entry point for investors researching Elicio Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Elicio Therapeutics, Inc. is a public biotechnology company based in the United States, trading under the ticker ELTX. The company focuses on developing innovative therapies for cancer treatment. With a market capitalization of approximately $70.4 million, Elicio Therapeutics is positioned within the growing biotech sector.

Latest news from Elicio Therapeutics, Inc.

All Elicio Therapeutics, Inc. news →

Research Elicio Therapeutics, Inc.

Alternate listings